“…In mammalian cells, PAs are involved in cell proliferation, differentiation, apoptosis, the synthesis of proteins and nucleic acids, the regulation of ion channel activity and the protection from oxidative injury [ 1 , 2 , 3 ]. Animals devoid of PA biosynthesis do not survive the early stages of embryonic development; notably, the supplementation of agmatine, a compound that belongs to the PA family and may serve as a precursor for Put (although exerting largely separate functions in mammal tissues), may be sufficient to rescue PA biosynthesis when the biosynthesis of Put is blocked (suggesting that the agmatine pathway is fully developed only later in life; for a discussion, see [ 4 ]). In fact, agmatine is a promising candidate for the treatment of several disorders, including neurodegenerative diseases, and highlights key roles for PAs in central nervous system (CNS) disorders [ 5 ].The cellular content of PAs is tightly regulated [ 1 , 2 , 3 ]; their biosynthesis is catalyzed by different enzymes including S-adenosylmethionine decarboxylase (AdoMetDC), ornithine decarboxylase (ODC), spermine synthase (SMS) and spermidine synthase (SRM) [ 6 ], while the enzymes N1-acetylpolyamine oxidase (PAOX), spermidine/spermine N1-acetyltransferase (SAT1) and spermine oxidase (SMOX) are involved in the PA catabolism ( Figure 1 ) [ 7 , 8 , 9 , 10 ].…”